Paper2043927
Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
Merritt JE and 9 others. Br J Pharmacol, 1991. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor. Papers, record 2043927. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2043927
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemodynamics | Major topic |
| Imidazoles | Major topic |
| Receptors, Prostaglandin | Major topic |
| Sterol O-Acyltransferase | Major topic |
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | |
| Adenosine Diphosphate | |
| Animals | |
| Blood Pressure | |
| Dose-Response Relationship, Drug | |
| Heart Rate | |
| Humans | |
| In Vitro Techniques | |
| Lung | |
| Macaca fascicularis | |
| Membranes | |
| Muscle Relaxation | |
| Muscle, Smooth, Vascular | |
| Prostaglandin Endoperoxides, Synthetic | |
| Receptors, Epoprostenol |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 978,455 | On the statistics of drug-receptor constants for partial agonists. | J Pharmacol Exp Ther | 1976 | https://conductscience.org/library/papers/978455 | PubMed |
| 2 | 4,827,395 | A highly sensitive adenylate cyclase assay. | Anal Biochem | 1974 | https://conductscience.org/library/papers/4827395 | PubMed |
| 3 | 7,470,763 | An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/7470763 | PubMed |
| 4 | 7,044,460 | Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin. | Br J Pharmacol | 1982 | https://conductscience.org/library/papers/7044460 | PubMed |
| 5 | 7,049,212 | Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7049212 | PubMed |
| 6 | 6,130,329 | Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial. | Lancet | 1983 | https://conductscience.org/library/papers/6130329 | PubMed |
| 7 | 6,136,920 | Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors. | Naunyn Schmiedebergs Arch Pharmacol | 1983 | https://conductscience.org/library/papers/6136920 | PubMed |
| 8 | 6,400,136 | Antithrombotic assessment and clinical potential of prostacyclin analogues. | Prog Med Chem | 1984 | https://conductscience.org/library/papers/6400136 | PubMed |
| 9 | 3,791,868 | Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. | Clin Sci (Lond) | 1986 | https://conductscience.org/library/papers/3791868 | PubMed |
| 10 | 3,545,351 | (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets. | Br J Pharmacol | 1987 | https://conductscience.org/library/papers/3545351 | PubMed |
| 11 | 2,436,701 | Prostacyclin analogues reduce ADP-ribosylation of the alpha-subunit of the regulatory Gs-protein and diminish adenosine (A2) responsiveness of platelets. | Br J Pharmacol | 1987 | https://conductscience.org/library/papers/2436701 | PubMed |
| 12 | 3,621,484 | Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives. | Circ Res | 1987 | https://conductscience.org/library/papers/3621484 | PubMed |
| 13 | 2,445,003 | Relaxation of isolated human pulmonary muscle preparations with prostacyclin (PGI2) and its analogs. | Prostaglandins | 1987 | https://conductscience.org/library/papers/2445003 | PubMed |
| 14 | 3,348,838 | Antiatherosclerotic and antihyperlipidemic effects of octimibate sodium in rabbits. | Atherosclerosis | 1988 | https://conductscience.org/library/papers/3348838 | PubMed |
| 15 | 3,328,202 | PGI2-receptors and molecular mechanisms in platelets and vasculature: state of the art. | Pharmacol Res Commun | 1987 | https://conductscience.org/library/papers/3328202 | PubMed |
| 16 | 3,385,635 | ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system. | J Pharmacol Exp Ther | 1988 | https://conductscience.org/library/papers/3385635 | PubMed |
| 17 | 2,474,350 | Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. | Br J Pharmacol | 1989 | https://conductscience.org/library/papers/2474350 | PubMed |
| 18 | 2,597,174 | A selective binding site for 3H-NECA that is not an adenosine A2 receptor. | Biochem Pharmacol | 1989 | https://conductscience.org/library/papers/2597174 | PubMed |
| 19 | 2,698,224 | Prostaglandin receptors in the cardiovascular system: potential selectivity from receptor subtypes or modified responsiveness. | Eicosanoids | 1989 | https://conductscience.org/library/papers/2698224 | PubMed |
| 20 | 1,710,526 | Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. | Br J Pharmacol | 1991 | https://conductscience.org/library/papers/1710526 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19,624,532 | Prostanoid receptor antagonists: development strategies and therapeutic applications. | Br J Pharmacol | 2009 | https://conductscience.org/library/papers/19624532 | PubMed |
| 1,710,526 | Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. | Br J Pharmacol | 1991 | https://conductscience.org/library/papers/1710526 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PTGIR | 5,739 | PubTator's text mining | https://conductscience.org/library/genes/5739 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2043927
GET https://conductscience.org/api/papers/v1/2043927/references?page=2